In the context of allergic diseases, several studies based on murine and in vitro models have highlighted the potential role of Bifidobacterium in reducing inflammation through the production of anti-inflammatory cytokines and suppressing Th2 immune response and IgE production [92,93,94]. This evidence concerns the gene IGHE and allergic disease.